Effect of Cyclosporine on Lesion Growth and Infarct Size within the White and Gray Matter
BackgroundIn a recent trial, cyclosporine A (CsA) failed to reduce infarct size in acute stroke patients treated with intravenous thrombolysis. White matter (WM) and gray matter (GM) may have distinct vulnerability to ischemia and response to therapy. Using final infarct size and lesion growth as en...
Main Authors: | Tae-Hee Cho, Elodie Ong, Nathan Mewton, Julien Bouvier, Fabien Chauveau, Thomas Ritzenthaler, Laura Mechtouff, Laurent Derex, Marielle Buisson, Yves Berthezène, Michel Ovize, Norbert Nighoghossian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00151/full |
Similar Items
-
Matrix Metalloproteinase-9 Relationship With Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy
by: Laura Mechtouff, et al.
Published: (2020-06-01) -
Impact of the reperfusion status for predicting the final stroke infarct using deep learning
by: Noëlie Debs, et al.
Published: (2021-01-01) -
Lenin’s Stroke
by: Norbert Nighoghossian, et al.
Published: (2021-06-01) -
Impact of the Thrombectomy Trials on the Management and Outcome of Large Vessel Stroke: Data From the Lyon Stroke Center
by: Louis Viannay, et al.
Published: (2018-08-01) -
Spontaneous reperfusion after in situ thromboembolic stroke in mice.
by: Anne Durand, et al.
Published: (2012-01-01)